← Leaderboards
Richard De La Garza
Yeshiva University
$6,424,321
Attributed
$7,027,504
Total exposure
12
Grants
10
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.7M · FY2008–19$2M$1.5M$1M$500K$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
Funding mix
By agency
NIH$7,027,504 · 12
By mechanism
R01$4,297,205 · 3
UG3$1,206,366 · 1
RC1$732,684 · 1
R21$581,295 · 2
M01$126,246 · 4
R03$83,708 · 1
Top collaborators
- Edythe D London1 shared
Others in their field
Top investigators on “Participant”
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Jeffrey P Krischer · University Of South Florida$407,724,307
- Lawrence Corey · Fred Hutchinson Cancer Center$333,313,234
- Mitchell J Malone · Texas A&M Research Foundation$320,373,312
- Gary D Acton · University Of California-Davis$320,373,312
- Albert Lazzarini · California Institute Of Technology$300,431,866
Research focus
ParticipantSelf AdministrationPharmaceutical PreparationsCravingPublic Health Medicine (Field)AttenuatedMethamphetaminePlacebo ControlExposure ToDopaminePlacebosRattusCocaineDoseEvaluationDouble-Blind MethodLaboratoriesBaseCocaine DependencesNeurotransmittersRivastigmineAcetylcholineOralExhibits
Grant awards (23)
Cannabidiol Effects on Craving and Relapse Prevention in Opioid Use Disorder$1,206,366
UG3 · FY2019 · DA
Rivastigmine and Huperzine A as Potential Treatments for Cocaine Addiction$460,647
R01 · FY2012 · DA · contact PI
Exercise as a Behavioral Treatment for Cocaine Dependence$195,625
R21 · FY2012 · DA · contact PI
Rivastigmine and Huperzine A as Potential Treatments for Cocaine Addiction$466,041
R01 · FY2011 · DA · contact PI
RTI-336 as a Treatment for Methamphetamine Dependence$368,515
R01 · FY2011 · DA · contact PI
Exercise as a Behavioral Treatment for Cocaine Dependence$234,750
R21 · FY2011 · DA · contact PI
Rivastigmine and Huperzine A as Potential Treatments for Cocaine Addiction$127,994
R01 · FY2011 · DA · contact PI
RIVASTIGMINE AS A TREATMENT FOR METHAMPHETAMINE DEPENDENCE$34,036
M01 · FY2011 · RR · contact PI
RIVASTIGMINE AND HUPERZINE A AS TREATMENTS FOR COCAINE DEPENDENCE$29,287
M01 · FY2011 · RR · contact PI
Rivastigmine and Huperzine A as Potential Treatments for Cocaine Addiction$471,738
R01 · FY2010 · DA · contact PI
Rivastigmine as a Treatment for Methamphetamine Dependence$379,913
R01 · FY2010 · DA · contact PI
RTI-336 as a Treatment for Methamphetamine Dependence$379,913
R01 · FY2010 · DA · contact PI
Modafinil and Escitalopram for Cocaine Addiction$367,223
RC1 · FY2010 · DA · contact PI
RIVASTIGMINE AS A TREATMENT FOR METHAMPHETAMINE DEPENDENCE$62,567
M01 · FY2010 · RR · contact PI
Rivastigmine as a Treatment for Methamphetamine Dependence$3,561
R01 · FY2010 · DA · contact PI
Rivastigmine and Huperzine A as Potential Treatments for Cocaine Addiction$502,990
R01 · FY2009 · DA · contact PI
Rivastigmine as a Treatment for Methamphetamine Dependence$383,750
R01 · FY2009 · DA · contact PI
RTI-336 as a Treatment for Methamphetamine Dependence$368,393
R01 · FY2009 · DA · contact PI
Modafinil and Escitalopram for Cocaine Addiction$365,461
RC1 · FY2009 · DA · contact PI
Rivastigmine as a Treatment for Methamphetamine Dependence$383,750
R01 · FY2008 · DA · contact PI
Cycloserine Enhancement of Extinction Learning$150,920
R21 · FY2008 · DA · contact PI
A STUDY OF THE EFFECT OF METHYLCOBALAMIN AND ADHD$356
M01 · FY2008 · RR · contact PI
Depression Enhances Vulnerability to Cocaine Relapse$83,708
R03 · FY2001 · DA